Invasive ductal carcinoma and invasive lobular carcinoma are both cancers that have grown beyond the place where they started — that is what “invasive” means in both names. They differ in two ways: where they begin, and how their cells grow. Ductal carcinoma starts in a milk duct and usually forms a distinct mass, while lobular carcinoma starts in the lobules — the glands that make milk — and its cells tend to spread out in single-file lines, which can make it harder to feel and sometimes harder to see on imaging.
Key Takeaways
- IDC begins in a milk duct; ILC begins in a lobule. Both are invasive, meaning the cells have grown into surrounding breast tissue.
- IDC cells usually clump together into a lump or mass. ILC cells often line up in single file because they lack a protein that helps cells stick to each other.
- That growth pattern is why ILC may be felt as thickening rather than a lump, and why extra imaging is sometimes used to map its extent.
- Neither name alone says how serious a cancer is. Size, lymph nodes, grade, and receptor results matter just as much for both.
- Every case is individual. Your pathology report and your care team are the source for what your type means for you.
Where Each One Begins
A milk duct is a small tube. Its job is to carry milk from the lobules to the nipple. When cancer starts in the lining of one of these tubes and then grows through the tube wall into nearby tissue, it is called invasive ductal carcinoma. You may also see it written as “invasive carcinoma of no special type” — wording that means the same thing. It is the most common invasive breast cancer, and our guide to invasive ductal carcinoma describes it on its own.
The lobules are the small, clustered glands where milk is produced. When cancer starts in a lobule and grows beyond it, it is called invasive lobular carcinoma, or ILC. It is the second most common invasive type. Our separate explainer on invasive lobular carcinoma goes deeper into how it is found and described.
The Real Difference: How the Cells Grow
The starting place explains the names, but the growth pattern explains most of the practical differences. IDC cells tend to stick together as they grow, forming a firmer area that can often be felt as a lump and seen as a mass on a mammogram.
ILC cells behave differently. They have usually lost a protein called E-cadherin, which works a little like glue between cells. Without it, the cells drift apart and arrange themselves in single-file lines, threading through normal tissue instead of building a ball. The cancer can be present across a wider area while changing the feel of the breast much less. This is also why ILC is sometimes described as having several separate areas, or appearing in both breasts — patterns a care team keeps in mind when planning imaging and follow-up. The wider family picture is set out in our pillar guide to types of breast cancer compared.
IDC and ILC, Side by Side
| Invasive Ductal Carcinoma (IDC) | Invasive Lobular Carcinoma (ILC) | |
|---|---|---|
| Starting place | A milk duct | A lobule (milk-producing gland) |
| Growth pattern | Cells clump together, often forming a mass | Cells line up in single file and thread through tissue |
| How it may be noticed | Often a lump that can be felt, or a mass seen on imaging | May feel like thickening or firmness; sometimes found only on imaging |
| Imaging | Usually visible as a distinct area on a mammogram | Can be subtle on a mammogram; ultrasound or MRI is sometimes added to see the full extent |
| Receptor results | Any pattern is possible; ER, PR, and HER2 are all tested | Often hormone-receptor-positive and HER2-negative, but individual results vary |
| What shapes the plan | Stage, grade, receptor results, and your overall health | The same — with extra attention to mapping the full area involved |
One row deserves emphasis: receptor results. For both types, the laboratory tests the cells for the estrogen receptor (ER), the progesterone receptor (PR), and HER2. Those results sit on top of the type name and carry a great deal of weight in planning, whichever type you have.
Why ILC Can Be Harder to Spot
A single-file growth pattern does not push tissue aside the way a growing mass does, so ILC may not produce the classic sign — a new, hard lump. Changes can be subtle: an area that feels thicker or firmer, a slight flattening, or a change in how the breast moves. On a mammogram, lines of cells can blend into normal tissue, so the size of an ILC can be underestimated until more imaging or surgery gives a clearer map.
None of this means ILC is usually found late or that it behaves worse — it means the finding process can take an extra step or two, and that new, persistent changes in how a breast feels are worth having checked even when there is no lump. If you are reading figures about how often any of this happens, current figures are published by the American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov), since published numbers are updated over time.
What Is the Same About Both
It can help to hold on to the similarities. Both are invasive cancers, so both are staged from 1 to 3 based on size and lymph node involvement (or stage 4 if cancer is found in distant parts of the body). Both are graded by how different the cells look from normal cells. Both are tested for the same three receptors. And for both, treatment discussions generally cover the same broad categories — surgery, possibly radiation, and medicines chosen around the receptor results — fitted to the individual report rather than to the type name alone.
It is also possible to have features of both in a single tumor; a report may describe a mixed ductal and lobular pattern. That is not an error — it is the laboratory describing what it sees.
Questions to Ask Your Doctor
- Is my cancer ductal, lobular, or does it have features of both?
- How large is the area involved, and how confident are we in that measurement?
- Would extra imaging, such as an MRI, help map the full extent in my case?
- What are my ER, PR, and HER2 results, and how do they shape the plan?
- Were lymph nodes checked, and what did that show?
- If this is lobular, should the other breast be imaged or followed in a particular way?
- Can we go through my pathology report together, line by line?
Frequently Asked Questions
Is one type more serious than the other?
Neither name, by itself, settles that question. Two cancers with the same type name can be very different in size, grade, lymph node involvement, and receptor results — and those details drive the outlook and the plan far more than the ductal-versus-lobular label. Comparisons between groups of patients exist in research, but they cannot describe your individual case; your care team can.
Can IDC and ILC appear in the same breast?
Yes. A tumor can show a mixture of both patterns, and separate ductal and lobular cancers can occasionally be found in the same person. The report will describe what was found, and the plan is built around the full picture.
If ILC is hard to see on a mammogram, how is it found?
Sometimes it is found because a change was felt and investigated with ultrasound or biopsy, and sometimes it appears on screening images after all. When ILC is suspected or confirmed, doctors sometimes add an MRI to estimate its full extent before surgery. Not everyone needs that step; it depends on the case.
Does the ductal-versus-lobular difference change surgery?
It can shape the conversation — for example, how much tissue is involved and how clearly the edges of the cancer can be defined — but the options discussed come from the same overall set, chosen around size, location, and your preferences. Your surgeon will explain what applies to your imaging and report.
Why does my report mention E-cadherin?
E-cadherin is the “glue” protein that helps cells stick together. Lobular cancer cells typically lack it, and the laboratory sometimes tests for it to help confirm that a cancer is lobular rather than ductal. It is one of several clues the pathologist uses, not a separate diagnosis.
Where can I read more about both types?
The National Cancer Institute publishes detailed, plain-language information about invasive breast cancer, including the lobular and ductal types.
Related Articles
- Types of Breast Cancer Compared — the complete guide to how the types are classified and how they differ.
- What Is Invasive Ductal Carcinoma? — the most common invasive type, explained on its own.
- Invasive Lobular Carcinoma Explained — how ILC grows, how it is found, and how reports describe it.
- DCIS vs Invasive Ductal Carcinoma — what changes when ductal cancer is no longer in situ.
- Understanding Your Breast Cancer Pathology Report — a plain-language walk through the words on the report.
This article is for general educational purposes only and is not medical, legal, or financial advice. It does not replace professional care. Talk to your doctor or care team about your own situation. If you think you may have a medical emergency, call 911.